Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Turmeric

BotanicalCurcuminBest with a meal

Useful mainly for adults with osteoarthritis pain seeking an adjunct to standard care.

Quick decision guide

May help most

Adults with osteoarthritis pain seeking an adjunct to standard care

Common dosing range

500-1000 mg/day of curcumin extract with piperine or enhanced bioavailability formulation

When to expect effects

Weeks

Watch out for

Poor bioavailability unless formulated with piperine or liposomal/phytosomal delivery; rare hepatotoxicity with high-bioavailability formulations

What is it

Turmeric (Curcuma longa) is a rhizomatous flowering plant in the ginger family, native to South Asia. Its bright yellow ground rhizome is used as a culinary spice and in traditional Ayurvedic and Chinese medicine. The main bioactive group are curcuminoids, of which curcumin is the most studied.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have osteoarthritis knee or hip pain and want a low-risk adjunct
You tolerate NSAIDs poorly and want an alternative anti-inflammatory
You use a high-bioavailability formulation (with piperine, liposomal, phytosomal, or micellar)

Probably skip if

You use plain turmeric powder - curcumin blood levels are negligible without enhanced absorption
You have gallstones or biliary disease
You are on anticoagulants or blood thinners without medical supervision
You are pregnant (medicinal doses are contraindicated)

Evidence at a glance

osteoarthritis pain

Good Evidence
Effect
Modest to moderate pain reduction; comparable to low-dose ibuprofen in some trials
Best fit
Adults with knee or hip osteoarthritis, especially those who cannot tolerate NSAIDs
Time
4-8 weeks

inflammatory markers (CRP, IL-6)

Good Evidence
Effect
Moderate reductions in CRP and IL-6 in pooled analyses
Best fit
People with elevated inflammatory markers associated with chronic conditions
Time
4-8 weeks

depression

Limited Evidence
Effect
Modest reduction in depression scale scores vs. placebo in small trials
Best fit
Adults with mild to moderate depression, possibly as an adjunct to standard antidepressants
Time
4-8 weeks

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

osteoarthritis pain

Supplement benefit
Good Evidence

Multiple RCTs and several meta-analyses of curcumin/turmeric for osteoarthritis show significant reductions in pain and functional limitation compared to placebo. A 2021 meta-analysis of 10 RCTs found benefit on pain and WOMAC scores. The effect size is modest and some head-to-head trials suggest efficacy comparable to low-dose ibuprofen, though these comparisons are limited. Enhanced-bioavailability formulations (with piperine, as BCM-95, Meriva, or Theracurmin) are used in positive trials; plain turmeric powder is unlikely to be effective.

Effect size
Modest to moderate pain reduction; comparable to low-dose ibuprofen in some trials
Time to effect
4-8 weeks
Best fit
Adults with knee or hip osteoarthritis, especially those who cannot tolerate NSAIDs
Less likely
People with severe OA requiring surgical intervention

Bottom line: Enhanced-bioavailability curcumin provides modest pain relief in osteoarthritis and is a reasonable adjunct when NSAIDs are contraindicated or poorly tolerated.

inflammatory markers (CRP, IL-6)

Biomarker support
Good Evidence

Meta-analyses of RCTs consistently find curcumin reduces circulating CRP, IL-6, and TNF-alpha levels in people with inflammatory conditions. Effect sizes are statistically robust across multiple pooled analyses. However, whether these biomarker changes translate to reduced clinical disease events (e.g., cardiovascular events) has not been demonstrated.

Effect size
Moderate reductions in CRP and IL-6 in pooled analyses
Time to effect
4-8 weeks
Best fit
People with elevated inflammatory markers associated with chronic conditions
Less likely
Healthy people with normal baseline inflammation

Bottom line: Curcumin reliably lowers inflammatory blood biomarkers; the clinical significance of this reduction beyond symptom relief has not been established.

depression

Supplement benefit
Limited Evidence

Several small RCTs and meta-analyses show curcumin supplementation reduces depression rating scale scores compared to placebo. The proposed mechanism involves modulation of serotonin, dopamine, and BDNF pathways. Trials are small (typically n=50-100), of short duration, and some used curcumin as an adjunct to antidepressants. Replication in larger independent trials is needed.

Effect size
Modest reduction in depression scale scores vs. placebo in small trials
Time to effect
4-8 weeks
Best fit
Adults with mild to moderate depression, possibly as an adjunct to standard antidepressants
Less likely
People with severe major depressive disorder

Bottom line: Preliminary RCT evidence suggests modest antidepressant effects; not a replacement for standard treatment.

How it works

Turmeric's medicinal effects are attributed primarily to its curcuminoid content (about 2 to 9 percent by weight of dried rhizome), with curcumin being the most abundant and best studied. Curcumin has demonstrated anti-inflammatory effects in cell and animal models through modulation of NF-kB, COX-2, lipoxygenases, and inflammatory cytokines. It also has antioxidant activity and modulates multiple cell signaling pathways implicated in chronic disease. The central pharmacological challenge with turmeric is bioavailability. Curcumin is poorly absorbed from the gut, rapidly metabolized by the liver, and quickly excreted, so plasma levels after a typical dose of plain turmeric powder are very low. Various formulation strategies have been developed to address this: piperine (from black pepper) blocks the metabolism of curcumin by inhibiting glucuronidation, increasing absorption by roughly 2000 percent. Liposomal, micellar, phytosomal, and nanoparticle formulations also raise plasma curcumin substantially. These formulations are the basis of many positive clinical trials; plain turmeric powder produces much smaller effects.

How to take it

1. Typical dose
500-1000 mg/day of standardized curcumin extract
2. Higher studied dose
Up to 2000 mg/day in some trials
3. Timing
With a fat-containing meal
4. With food
With food containing fat (improves absorption of curcumin)
5. Split dosing
500 mg twice daily maintains more consistent levels than single large dose
6. How long to try
6-12 weeks to assess benefit for joint pain

What to track

Joint pain score (e.g., WOMAC or VAS scale)
Physical function and mobility
Any GI side effects or signs of liver injury (jaundice, dark urine, right-sided abdominal pain)
Bleeding or bruising if on anticoagulants

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Turmeric root powder

The culinary form. Good for food use; not ideal for therapeutic effects. Pair with black pepper and fat to improve absorption.

Very low oral bioavailability; trace plasma curcumin from typical doses.

Curcumin extract (95 percent curcuminoids)

Concentrated form. Often combined with piperine (BioPerine) for absorption.

Concentrated curcuminoids but still low absorption without enhancement.

Curcumin + piperine combinations

Common cost-effective enhancement. Note piperine also affects metabolism of many medications.

Piperine inhibits curcumin glucuronidation, raising absorption by approximately 2000 percent.

Liposomal or phytosomal curcumin (Meriva, BCM-95, Theracurmin)

More expensive but most effective. Lower doses produce equivalent or greater clinical effects than higher doses of plain curcumin.

10 to 50 times higher plasma curcumin than plain extract.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

GI upsetNauseaDiarrheaHeadacheYellow staining of stool

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Medicinal doses are contraindicated in pregnancy due to potential uterine-stimulating effects; culinary use (spice amounts) is considered safe.

Interactions

warfarin / anticoagulants / antiplatelet drugsModerate

Curcumin has mild anticoagulant and antiplatelet activity that can compound warfarin, aspirin, or clopidogrel effects

CYP3A4 and CYP2D6 substratesModerate

Curcumin inhibits CYP3A4 and CYP2D6 enzymes, potentially raising levels of many medications metabolized by these pathways

diabetes medicationsMinor

May enhance blood-glucose-lowering effects; monitor for hypoglycemia

iron supplementsMinor

High-dose curcumin may reduce non-heme iron absorption; do not take together

Documented interactions

Protocols featuring Turmeric

Evidence-backed routines where Turmeric plays a role.

Systemic Inflammation Support

longevity

Chronic low-grade systemic inflammation (sometimes called "inflammaging") is a unifying mechanism behind cardiovascular disease, type 2 diabetes, neurodegeneration, autoimmune conditions, and accelerated aging. Unlike acute inflammation (which is necessary and beneficial), chronic inflammation drives tissue damage over years. Measurable markers include hsCRP, IL-6, TNF-alpha, fibrinogen, and homocysteine. This stack targets chronic inflammation through complementary mechanisms: curcumin (NF-kB and COX-2 inhibition with the bioavailability problem solved by phytosome forms), omega-3 EPA (shifts eicosanoid production toward less inflammatory series-3), quercetin (mast cell stabilization and NF-kB modulation), and boswellia (5-LOX inhibition through a distinct pathway). This is distinct from Joint Health & Mobility (osteoarthritis-specific) and Daily Calm (stress-driven). For systemic inflammation, the upstream causes — visceral fat, ultra-processed food intake, chronic stress, poor sleep, sedentary lifestyle — matter more than supplements. The stack is a complementary layer.

Joint Health & Mobility

recovery

Joint discomfort is one of the most universal aging symptoms — and one of the most over-supplemented categories in the entire industry. The literature for glucosamine and chondroitin is genuinely mixed: some trials show modest pain and function improvements in moderate osteoarthritis; others find no effect over placebo. Omega-3 has more consistent evidence for inflammatory joint pain. Curcumin (with appropriate bioavailability enhancement) has rapidly accumulating trial evidence comparable to NSAIDs in mild-to-moderate osteoarthritis. UC-II (undenatured type II collagen) has small but clean trials for knee osteoarthritis. This stack is for everyday joint maintenance and mild-to-moderate osteoarthritis — not a substitute for orthopedic care of serious joint disease.

Autoimmune Foundation

autoimmune

Autoimmune diseases affect roughly 24 million Americans across 80+ conditions: rheumatoid arthritis, lupus, multiple sclerosis, inflammatory bowel disease (Crohn''s, UC), psoriasis, Hashimoto''s, type 1 diabetes, celiac, Sjögren''s, and dozens more. They share core pathology: the immune system mistakenly attacks the body''s own tissues, driven by genetic predisposition + environmental triggers (infections, gut microbiome dysbiosis, stress, certain medications, sometimes specific exposures). The modern treatment revolution is biologic therapy (DMARDs: methotrexate, sulfasalazine; biologics: adalimumab, infliximab, etanercept, secukinumab, dupilumab; small molecules: tofacitinib, etc.) — these are genuinely transformative for moderate-to-severe disease. This protocol is a FOUNDATIONAL baseline for adults with an autoimmune diagnosis — NOT a substitute for proper rheumatology, gastroenterology, neurology, or endocrinology care. It targets the universal anti-inflammatory and immune-modulating pathways that affect every autoimmune patient: vitamin D (where deficiency is strongly associated with autoimmune disease activity), omega-3 EPA (anti-inflammatory eicosanoid shift), curcumin (NF-kB inhibition), NAC (glutathione support for oxidative stress), and vitamin K2 (mineral metabolism and growing evidence for inflammatory modulation). CRITICAL: Beware "autoimmune cure" marketing. There''s a substantial wellness-industry ecosystem promising that diet, supplements, or "leaky gut protocols" can reverse autoimmune disease. The honest evidence: lifestyle + supplements measurably reduce disease activity and symptom severity but do NOT replace immunomodulator therapy in moderate-to-severe disease. Don''t stop your DMARD or biologic based on supplement marketing.

RA & Joint Autoimmune

autoimmune

Rheumatoid arthritis affects roughly 1.3 million Americans; psoriatic arthritis another 1 million; ankylosing spondylitis around 250,000. Together with the smaller seronegative spondyloarthropathies they form the family of joint-dominant autoimmune diseases — seropositive (RF, anti-CCP) or seronegative — where the immune system attacks synovium, entheses, and cartilage. Untreated, the consequences are joint destruction, deformity, disability, and significant excess cardiovascular and lung morbidity. The modern standard of care is dramatically better than it was 25 years ago: DMARDs (methotrexate first-line, sulfasalazine, leflunomide, hydroxychloroquine), biologics (anti-TNF: adalimumab, etanercept, infliximab; IL-6: tocilizumab, sarilumab; B-cell: rituximab; T-cell co-stim: abatacept), and small-molecule JAK inhibitors (tofacitinib, upadacitinib, baricitinib). The 2021 ACR RA Guideline recommends early aggressive treatment with methotrexate, escalating to biologic or JAK inhibitor if methotrexate is insufficient. This protocol is a COMPLEMENT to — not a substitute for — disease-modifying therapy. The five supplements stacked here target the inflammatory pathways most relevant to joint autoimmunity: omega-3 EPA (eicosanoid shift, the most evidenced supplement in RA), curcumin (NF-kB and COX-2 inhibition, with trial evidence specifically in RA), vitamin D (deficiency strongly linked to disease activity), boswellia (5-LOX inhibition, evidence strongest in osteoarthritis but mechanistically applicable), and ginger (COX/LOX inhibition, modest meta-analytic evidence). Layer this on top of the Autoimmune Foundation protocol for the universal autoimmune baseline. CRITICAL: see a rheumatologist FIRST. Early aggressive treatment with methotrexate (with or without a biologic) is the new standard of care for moderate-to-severe RA. The biologic-era outcomes — remission, no joint damage on imaging, normal function — are dramatically better than the older-generation methotrexate-only outcomes, which themselves were dramatically better than the pre-DMARD era. Do NOT replace methotrexate or a biologic with supplements.

IBD Support (Crohn's & Ulcerative Colitis)

autoimmune

Inflammatory bowel disease (IBD) affects roughly 3 million Americans across two main forms: Crohn''s disease (can involve any segment of the GI tract, transmural inflammation, often complicated by strictures, fistulas, and surgical resections) and ulcerative colitis (continuous mucosal inflammation limited to the colon, with bloody diarrhea and urgency as hallmark symptoms). This is fundamentally different from IBS (irritable bowel syndrome), which is a functional disorder without structural damage. IBD involves chronic, often progressive intestinal inflammation, ulceration, and sometimes systemic complications (uveitis, arthritis, primary sclerosing cholangitis, increased colorectal cancer risk). The modern treatment revolution is biologic and small-molecule therapy: 5-ASAs (mesalamine for UC), corticosteroids (short-term flare control only), immunomodulators (azathioprine, methotrexate), TNF inhibitors (infliximab/Remicade, adalimumab/Humira), integrin antagonists (vedolizumab/Entyvio), IL-12/23 inhibitors (ustekinumab/Stelara, risankizumab/Skyrizi), and JAK inhibitors (tofacitinib, upadacitinib). These are genuinely transformative — biologic-era outcomes have dramatically reduced surgery rates, steroid dependence, and hospitalizations. This protocol is an ADJUNCTIVE supplement layer for adults with an established IBD diagnosis under gastroenterology care — NOT a substitute for proper medical therapy. It targets: nutrient deficiencies common in IBD due to malabsorption and inflammation (vitamin D, iron, B12), gut barrier support (L-glutamine), and inflammation modulation (omega-3 EPA, curcumin). Trial evidence is strongest for curcumin (Lang 2015 — curcumin + mesalamine outperformed mesalamine alone in UC remission) and vitamin D normalization (Ananthakrishnan 2013 — associated with reduced surgery risk in Crohn''s). CRITICAL: Beware "IBD cure" marketing. There is a substantial ecosystem promising that diet alone, supplements alone, or "leaky gut protocols" can reverse IBD. The honest evidence: supplements + diet measurably help but do NOT replace biologics or immunomodulators in moderate-to-severe disease. Stopping a biologic based on supplement marketing is one of the most reliable ways to lose intestinal tissue.

Post-Workout Recovery

recovery

Recovery determines your next training session, not the workout you just finished. The best-evidenced supplemental levers are unglamorous: enough protein to drive muscle protein synthesis, creatine to maintain phosphocreatine stores, and a small set of anti-inflammatory aids for high-volume blocks or competition stretches. This protocol assumes you are training consistently — three or more sessions per week — and want to recover better between them. If you train less, the protein you eat at meals is sufficient.

Psoriasis Support

skin conditions

Psoriasis is a chronic, immune-mediated inflammatory disease affecting 2-3% of adults. The hallmark is accelerated keratinocyte turnover — skin cells replicating every 3-5 days instead of the normal 28-30 — driven by a Th17/IL-23 immune axis. Clinically that shows up as well-demarcated red plaques with silvery scale, classically on the elbows, knees, scalp, and lower back. Psoriasis is not just a skin disease: it carries substantial comorbid risk. Roughly 30% of patients develop psoriatic arthritis, and the cohort as a whole runs higher cardiovascular disease, metabolic syndrome, and depression rates than the general population. Treatment is genuinely multi-modal — topical corticosteroids and vitamin D analogs (calcipotriol) for limited disease, phototherapy for wider involvement, and systemic biologics targeting IL-17 (secukinumab/Cosentyx), IL-23 (risankizumab/Skyrizi, guselkumab/Tremfya, ustekinumab/Stelara), or TNF-alpha (adalimumab/Humira) for moderate-to-severe disease. If you have moderate-to-severe psoriasis — significant body surface area, scalp/genital/palmar-plantar involvement, joint symptoms, or quality-of-life impact — see a dermatologist. The biologics era has been transformative; PASI 90 (90% lesion clearance) is now a realistic goal for most patients, not the exception. Supplements occupy a supportive role: they can blunt systemic inflammation, correct deficiencies that worsen disease activity, and address the cardiometabolic comorbidity burden. They don't replace appropriate dermatologic care for anything beyond mild localized disease.

Endometriosis Support

hormones

Endometriosis affects 10% of reproductive-age women and is one of the most under-diagnosed conditions in medicine — average diagnostic delay is 7-10 years. The pathology involves estrogen-dependent inflammatory lesions outside the uterus, driving severe menstrual pain, pelvic pain, painful intercourse, and infertility. Conventional treatment includes hormonal suppression (continuous oral contraceptives, GnRH analogs) and surgical excision. The supplement category has growing but still preliminary evidence: omega-3 EPA for inflammatory mediator modulation, magnesium for cramping and mood, NAC for lesion size reduction (small trial), and curcumin for inflammation. None of these replace proper medical management of confirmed endometriosis — they support symptom management alongside it. If you have severe menstrual pain that affects daily function, painful intercourse, infertility, or pelvic pain that doesn''t respond to over-the-counter pain relief — please see a gynecologist who specifically treats endometriosis. Many general OBs miss it.

Food sources

Turmeric, ground (1 tsp)

Amount
~200 mg curcuminoids
%DV

Fresh turmeric root (1 inch)

Amount
~60 to 100 mg curcuminoids
%DV

Curry powder (1 tsp)

Amount
~50 to 100 mg curcuminoids
%DV

Golden milk (1 cup with 1 tsp turmeric)

Amount
~200 mg curcuminoids
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Enhanced bioavailability formulation clearly stated: with piperine (BioPerine), phytosomal (Meriva), BCM-95, or micellar/liposomal
Curcuminoid content as percentage or milligrams per dose
Third-party tested for heavy metals and identity

Be skeptical of

Cures inflammation
Prevents cancer
Equivalent to pharmaceutical anti-inflammatories
Plain turmeric powder products that do not address bioavailability

Frequently asked questions

Do I need black pepper with turmeric?

Yes, if you want meaningful absorption from plain turmeric powder. Piperine in black pepper inhibits the liver enzyme that destroys curcumin, raising blood levels by roughly 20-fold. If your supplement is already formulated as liposomal, micellar, or phytosomal curcumin, additional black pepper is less important.

What's the difference between turmeric and curcumin?

Turmeric is the whole rhizome (root). Curcumin is the most studied of the bioactive curcuminoids in turmeric, making up roughly 2 to 9 percent of the dried root. Curcumin extracts concentrate the active compound; whole turmeric provides curcuminoids plus essential oils and other phytochemicals.

How much turmeric is in a teaspoon?

About 2 to 3 grams of turmeric powder per teaspoon, providing roughly 60 to 200 mg of total curcuminoids depending on quality. Trial doses use 500 to 1,500 mg of standardized curcumin, the equivalent of much more than is practical to get from food.

Will turmeric thin my blood?

It has mild antiplatelet activity. At culinary doses this is rarely clinically significant. At supplement doses (500 to 2,000 mg curcumin/day), it can add to the effect of warfarin, aspirin, and other blood thinners. Coordinate with your prescriber.

Is turmeric bad for my liver?

Rare cases of liver injury have been linked to high-bioavailability curcumin products in recent reports. Most users have no issue, but stop and seek evaluation if you develop fatigue, jaundice, nausea, or right-upper-quadrant pain.

References by claim

osteoarthritis pain

Zeng et al., 2021PMC (2021) link

Bideshki et al., 2024PubMed (2024) link

inflammatory markers (CRP, IL-6)

Gorabi et al., 2022PubMed (2022) link

Sahebkar et al., 2014PubMed (2014) link

depression

Fusar-Poli et al., 2020PubMed (2020) link

Ng et al., 2017PubMed (2017) link

Safety

Memorial Sloan Kettering — TurmericMSKCC About Herbs link

Track Turmeric with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.